9amHealth is a technology company.
9amHealth is a technology company.
9amHealth has raised $30.0M across 3 funding rounds.
9amHealth has raised $30.0M in total across 3 funding rounds.
9amHealth has raised $30.0M in total across 3 funding rounds.
9amHealth's investors include 7wire Ventures, Define Ventures, Founders Fund, F-Prime Capital Partners, Lux Capital, The General Partnership, Louis Beryl, Sathvik Bilakanti.
9amHealth is a virtual healthcare company delivering comprehensive cardiometabolic care for conditions like obesity, prediabetes, type 2 diabetes, high blood pressure, high cholesterol, and hypertension.[1][2][3][4][5] It offers personalized care plans through unlimited access to a multidisciplinary Care Team—including licensed providers, pharmacists, diabetes specialists, and nutritionists—plus same-day prescriptions with at-home delivery, at-home labs, and lifestyle guidance via affordable membership plans.[1][2][5] Serving individuals, employers, health plans, and pharmacy benefit managers (PBMs), 9amHealth solves fragmented chronic care by providing a seamless, whole-body virtual model that reduces costs, commutes, and wait times while prioritizing evidence-based practices like comprehensive evaluations and FDA-approved medications.[1][2][4] The company, founded in 2021 and headquartered in San Diego, has gained growth momentum through partnerships with Novo Nordisk, Mark Cuban Cost Plus Drug Company, Solera Health, Prescryptive Health, SmithRx, and Smart Meter, plus backing from investors like 7Wire Ventures, Cigna Ventures, Founders Fund, Define Ventures, Human Capital, and iSeed Ventures.[1][2][3][4]
9amHealth was founded in 2021 by the team behind mySugr, a successful diabetes management app, bringing proven expertise in digital health tools to address broader chronic conditions.[1][2][4] The idea emerged from recognizing gaps in traditional care—long waits, fragmented services, and barriers for patients like truck drivers who struggle with in-office visits—prompting a shift to a fully virtual, integrated model for cardiometabolic health.[5][8] Early traction came from employer partnerships, including major tech companies deploying their weight management programs enhanced by integrations like Smart Meter's cellular scales for real-time data, establishing a foundation for scalable, evidence-based virtual care.[4]
9amHealth rides the explosion of GLP-1 obesity medications and virtual care adoption, capitalizing on a "once-in-a-lifetime shift" where patients seek integrated diagnostics, prevention, and treatment amid rising cardiometabolic conditions affecting millions.[2][4] Timing aligns with telehealth maturation post-pandemic, employer demands for employee wellness (e.g., tech firms addressing comorbidities), and scrutiny on unregulated compounded drugs, positioning 9amHealth to influence standards through evidence-based, scalable models.[2][4] By partnering with payers and pharma, it drives ecosystem-wide improvements in chronic care accessibility, cost efficiency, and outcomes, bridging digital health with traditional medicine.[3]
9amHealth is poised for expansion via deepening employer and payer integrations, leveraging obesity drug momentum to broaden into preventive services and adjacent conditions.[2][3][4] Trends like AI-enhanced personalization, further GLP-1 accessibility, and remote monitoring will shape its trajectory, potentially evolving it into a dominant virtual cardiometabolic platform with global reach. As chronic care digitizes, 9amHealth's mySugr roots and partnership agility position it to redefine whole-health standards, delivering the affordable, seamless model that sparked its 2021 launch.[1][2]
9amHealth has raised $30.0M across 3 funding rounds. Most recently, it raised $10.0M Series A in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2024 | $10.0M Series A | 7wire Ventures, Define Ventures, Founders Fund, F-Prime Capital Partners, Lux Capital, The General Partnership, Louis Beryl, Sathvik Bilakanti | |
| Apr 1, 2022 | $16.0M Series A | 7wire Ventures, Define Ventures, Founders Fund, F-Prime Capital Partners, Lux Capital, The General Partnership, Louis Beryl, Sathvik Bilakanti | |
| Sep 1, 2021 | $4.0M Seed | Define Ventures, Founders Fund, Lux Capital, The General Partnership, Louis Beryl, Sathvik Bilakanti |